CELLDEX THERAPEUTICS INC NEW
CLDX·15117B202·US·Common Stock·Healthcare - Biotechnology-13D/G
CLDX (CELLDEX THERAPEUTICS INC NEW) is held by 115 institutional investors as of Q1 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($271.5M), BlackRock, Inc. ($170.3M), FMR LLC ($118.9M). Net institutional sentiment: Mixed.
115
Holders
Avg rating(24 Elite)
$1.4B
Total Value
61% (119)
Fund Consensus
65 buying - 41 selling
Who's Trading
ActivistKYKynam Capital Management, LP8.8%May 15, 2026
InsiderJAJimenez Freddy A.Sell $121KDec 4, 2025
InsiderWMWright Richard M.Sell $1.2MNov 13, 2025
InsiderJAJimenez Freddy A.Sell $8KAug 13, 2025
InsiderJAJimenez Freddy A.Sell $11KAug 13, 2025
13F: Insider & Congress:
Showing 1-20 of 119
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer